Now showing items 1-4 of 4
After the GEMINI-ACS-1 trial
(TURKISH SOC CARDIOLOGY, 2017)
The GEMINI-ACS-1 trial has recently been published. It was designed to test whether low dose rivaroxaban as an antithrombotic agent is as safe as aspirin in patients with acute coronary syndromes (ACS). The trial is important ...
Future of advanced heart failure and mechanical support devices: A Cardiology-Cardiovascular Surgery Consensus Report
(TURKISH SOC CARDIOLOGY, 2016)
Heart failure is a progressive disease. A considerable number of patients eventually reach an advanced or terminal phase, in spite of developments in diagnostic procedure, alternative treatments that can slow progression, ...
Practical approach to acute heart failure with algorithms
(TURKISH SOC CARDIOLOGY, 2009)
Acute heart failure syndrome is a heterogeneous group, which requires distinct therapeutic approaches. Diuretics and/or vasodilators for patients with high blood pressure and inotropic agents for patients with low left ...
Advanced heart failure and future of mechanical assist devices: a Consensus Report on Cardiology and Cardiovascular Surgery
(BAYCINAR MEDICAL PUBL-BAYCINAR TIBBI YAYINCILIK, 2016)
Heart failure is a progressive disease. A considerable portion of patients reach an advanced or terminal phase later or sooner, despite all of the developments in diagnosis, management, and follow-up and alternatives which ...